High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis
JAMA Netw Open. 2026 May 1;9(5):e2614620. doi: 10.1001/jamanetworkopen.2026.14620.ABSTRACTIMPORTANCE: High-dose inactivated influenza vaccine (HD-IIV) was developed to enhance immune responses in older adults and has demonstrated superior protection against laboratory-confirmed influenza (LCI) and s

